Monthly Archives: May 2016

What trends are reshaping the pharma Landscape in 2016?

Not only the patients or physicians are increasing the mobile and digital usage on their needs, we are also understanding that more than ever the Health Authorities, regulatory agencies and payers are requesting more digital services and using more digital products through online and mobile usage to address traditional and new requirements. Combined with this growing usage and demanding, pharma companies have amazing opportunities to provide content and information essential to obtain products approvals, increase the success rates for reimbursement and drive more awareness around products efficacy, safety and clinical trials results.

Understanding Centricity Blog

2016: Global Top 12 Pharma and Biotech companies by Revenue in 2015

The global Pharmaceutical market has reached an incredible milestone of global sales revenue in 2015 of almost €1.2 trillion, with strong forecasts to increase to €1.6 trillion by 2018.

Only the 12 largest companies in the Pharmaceutical & Biotechnology landscape achieved €325 billion of revenue only from the Pharmaceutical Divisions (e.g. J&J Business Units divisions are: Pharma, Consumer and Medical Devices), reflecting already a market share of 31.8%.

Understanding Centricity Blog

Top 12 Pharmaceutical & BioTechnology Companies in 2016 – Ranking by Revenue and Market Potential index

Top 12 Pharmaceutical & BioTechnology in 2016 – Ranking
The global Pharmaceutical market has reached an incredible milestone of global sales revenue in 2015 of almost €1.2 trillion, with strong forecasts to increase to €1.6 trillion by 2018.
Only the 12 largest companies in the Pharmaceutical & Biotechnology landscape achieved the impressive milestone of €325 billion revenue only from the Pharmaceutical Divisions (e.g. J&J Business Units divisions are: Pharma, Consumer and Medical Devices), reflecting already a market share of 31.8%.
The Pharma&BioTech market globally shows high levels of consolidation and maturity, where in the last year the activities around M&A were intense and the concentration in terms of market share was quite expressive.
Looking at the primary location of half of the 12 companies, United States have a strong representation of 6 companies, followed by different European countries (Switzerland [2], U.K. [2] and then France [1] and Germany [1]).

Understanding Centricity Antonio Pesqueira

Essential components of a Multichannel and Digital strategic planning in Pharma: Content and Integration are key (Part V)

Some of the biggest challenges in Multichannel Marketing (MCM) programs, have to do with the delivered content itself and how the responsible departments plans the master data design models to support the entire program and how systems, data and platforms integration are architected to deliver results and sustainable outcomes.